From: Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
Physical Health Composite Score | Mental Health Composite Score | |||
---|---|---|---|---|
Effect | β | p | β | p |
Intercept* | 65.08 | <.0001 | 69.31 | <.0001 |
Age at inclusion | -0.19 | 0.043 | -0.22 | 0.06 |
Gender (Male vs. Female) | -1.51 | 0.43 | -6.95 | 0.005 |
Disease duration | -0.1 | 0.41 | -0.04 | 0.82 |
Disease course (SP vs. RR) | 3.69 | 0.24 | 8.39 | 0.037 |
Relapse rate 2-yrs before study entry | 0.69 | 0.75 | 0.62 | 0.83 |
EDSS | -3.44 | 0.0003 | -0.85 | 0.47 |
BDI | -0.59 | <.0001 | -1.44 | <.0001 |
FSS | -6.69 | <.0001 | -2.08 | 0.019 |
MMSE-c | -0.28 | 0.44 | 0.45 | 0.34 |
IFN-β treatment (Yes vs No) | -0.09 | 0.97 | 2.75 | 0.36 |
Relapse rate change after 2-yrs | 2.15 | 0.42 | 0.60 | 0.84 |
EDSS change after 2-yrs | -1.57 | 0.26 | 1.59 | 0.31 |
BDI change after 2-yrs | -0.60 | <.0001 | -1.08 | <.0001 |
FSS change after 2-yrs | -5.21 | <.0001 | -2.48 | 0.01 |
MMSE-c change after 2-yrs | -0.35 | 0.53 | -0.16 | 0.81 |
Time** | 1.32 | 0.54 | 3.33 | 0.19 |
Time × IFN-β treatment (Yes vs No) | -1.65 | 0.58 | -9.19 | 0.01 |